Cargando…
Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease
A critical goal of Alzheimer disease research is to identify disease biomarkers that can be used in clinical trials to assist in the adjudication of treatment effects. While clinical validation remains a goal for many potential Alzheimer disease biomarkers, the rapid proliferation of markers has spa...
Autor principal: | Dickerson, Bradford C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949587/ https://www.ncbi.nlm.nih.gov/pubmed/20619002 http://dx.doi.org/10.1186/alzrt45 |
Ejemplares similares
-
Quantitative Analysis of Synthetic Magnetic Resonance Imaging in Alzheimer’s Disease
por: Lou, Baohui, et al.
Publicado: (2021) -
Molecular magnetic resonance imaging
por: Hengerer, A, et al.
Publicado: (2006) -
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease
por: Schwarz, Adam J., et al.
Publicado: (2019) -
Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021) -
Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer's disease
por: Bayram, Ece, et al.
Publicado: (2018)